Ep. 121 - ASCO, CRISPR IP & CStone
BioCentury This Week
00:00
The Potential of a Crisper With Bacterial Phases
sea stone, once on a fast track to become a leading china biotec has found itself in limbo for the past couple of months. On april first to day, we finally get the results of the company's investigation into the matter. The good news for sestone is that the money is recoverable. But the question is, and i guess we'll get our first look at this when the stock begins trading again to morrow, is whether investors still have confidence in the company.
Transcript
Play full episode
